Am. J. Respir. Crit. Care Med., Vol 153, No. 6, 06 1996, 1831-1837.
The effects of recombinant human thrombomodulin on endotoxin-induced multiple-system organ failure in rats
N Hasegawa, TG Kandra, AW Husari, S Veiss, WT Hart, J Hedgpeth, R Wydro and TA Raffin
Division of Pulmonary and Critical Care Medicine, Stanford University Medical Center, Stanford, California 94305-5236, USA.
Activation of the coagulation system is postulated to play an important
role in the pathogenesis of endotoxin-induced tissue injury. Thrombomodulin
(TM) is an endothelial cell membrane glycoprotein receptor for thrombin.
Once bound to TM, thrombin loses its procoagulant activity, which results
in decreased clotting. In addition, the binding of thrombin to TM activates
the endogenous anticoagulant pathway through protein C. We studied the
effect of recombinant human TM (rh-TM) on endotoxin-induced multiple-system
organ failure (MSOF) in Sprague-Dawley rats weighing 400 to 450 g: 2 mg/kg
of rh-TM was injected (T1/2 = 4.5 h) 30 min prior to intravenous injection
of 20 mg/kg of Escherichia coli endotoxin. The study presented here
consisted of three separate experiments. Experiment 1: 24-h survival study.
Experiment 2: multiple-system organ microthrombi study in which 125I-human
fibrinogen was injected 30 min prior to an endotoxin or saline injection
and tissue microthrombi formation was assessed by measuring the percentage
of organ radioactivity (lung, heart, liver, and kidney) against total
injected radioactivity (microthrombi index, MI) 2.25 h after an endotoxin
or saline injection. Experiment 3: endotoxin-induced MSOF study in which
125I-rat albumin was injected 5 h after an endotoxin or saline injection,
and endotoxin-induced organ injury was evaluated by measuring tissue
wet-to-dry ratios (W/D) and tissue-to-plasma 125I-rat albumin concentration
ratios (T/P) 8 h after the endotoxin or saline injection. Blood
contamination in samples from Experiments 2 and 3 was corrected by using
131I-rat albumin measurements. Pretreatment with rh-TM improved the
survival from 12 h through 23 h as compared with that of the endotoxin
control group (p < 0.05). However, at 24 h, after essentially all
injected rh-TM had been eliminated, there was no difference in survival.
Significant reductions in MI, W/D, and T/P in the organs sampled were
observed in the rh-TM pretreated groups (p < 0.05). In conclusion, rh-TM
improved short-term but not overall survival and decreased MSOF in
endotoxemic rats.
This article has been cited by other articles:

|
 |

|
 |
 
T. Ozaki, C. Anas, S. Maruyama, T. Yamamoto, K. Yasuda, Y. Morita, Y. Ito, M. Gotoh, Y. Yuzawa, and S. Matsuo
Intrarenal administration of recombinant human soluble thrombomodulin ameliorates ischaemic acute renal failure
Nephrol. Dial. Transplant.,
January 1, 2008;
23(1):
110 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Weijer, C. W. Wieland, S. Florquin, and T. van der Poll
A thrombomodulin mutation that impairs activated protein C generation results in uncontrolled lung inflammation during murine tuberculosis
Blood,
October 15, 2005;
106(8):
2761 - 2768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suzuki, Y. Muto, K. Fushihara, K.-i. Kanemoto, H. Iida, E. Sato, C. Kikuchi, T. Matsushima, E. Kato, M. Nomoto, et al.
J. Pharmacol. Exp. Ther.,
May 1, 2004;
309(2):
607 - 615.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Rijneveld, S. Weijer, S. Florquin, C. T. Esmon, J. C. M. Meijers, P. Speelman, P. H. Reitsma, H. Ten Cate, and T. van der Poll
Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide
Blood,
March 1, 2004;
103(5):
1702 - 1709.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Murciano, D. Harshaw, D. G. Neschis, L. Koniaris, K. Bdeir, S. Medinilla, A. B. Fisher, M. A. Golden, D. B. Cines, M. T. Nakada, et al.
Platelets inhibit the lysis of pulmonary microemboli
Am J Physiol Lung Cell Mol Physiol,
March 1, 2002;
282(3):
L529 - L539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Christofidou-Solomidou, S. Kennel, A. Scherpereel, R. Wiewrodt, C. C. Solomides, G. G. Pietra, J.-C. Murciano, S. A. Shah, H. Ischiropoulos, S. M. Albelda, et al.
Vascular Immunotargeting of Glucose Oxidase to the Endothelial Antigens Induces Distinct Forms of Oxidant Acute Lung Injury : Targeting to Thrombomodulin, But Not to PECAM-1, Causes Pulmonary Thrombosis and Neutrophil Transmigration
Am. J. Pathol.,
March 1, 2002;
160(3):
1155 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. B. Taylor Jr, D. J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A. C. K. Chang, Z. Laszik, S. Kosanke, G. Peer, and C. T. Esmon
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis
Blood,
March 1, 2000;
95(5):
1680 - 1686.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society
|
|
|